1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow John Waters: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer. CYTALUX™ (pafolacianine) injection preoperatively - Esophageal Cancer, Gastrointestinal Cancers | Phase 2 | Recruiting | John Waters | 50 | 2025-08-19 | 2026-06-05 |
Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1)
Pafolacianine (1)
United States (1)